Literature DB >> 25425961

Proton sharing and transfer in some zwitterionic compounds based on 4-oxo-4-((1-phenethylpiperidin-4-yl)(phenyl)amino)alcanoic acids.

Gary S Nichol1, Vlad K Kumirov1, Ruben Vardanyan1, Victor J Hruby1.   

Abstract

Three compounds, each derived from Fentanyl and differing essentially only in the length of a carboxylic acid chain, were synthesized and yielded four crystal structures three of which share several structural similarities, including the length of the chain, while the fourth, with a shorter chain, is quite different. The chain length has a significant influence on the crystal structures formed. The 'three atom' chain compounds are all solvated zwitterions which feature a hydrogen-bonded 'dimer' between adjacent zwitterions. The formation of this large dimer leaves available a second carboxylate O atom to take part in hydrogen bonding interactions with solvent molecules. The shorter 'two atom' chain compound was difficult to crystallize and required the use of synchrotron radiation to measure X-ray diffraction data. It does not form the same dimer motif observed in the 'three atom' chain compounds and has not formally formed a zwitterion; although there is evidence of proton sharing or disorder X-ray data are insufficient to create a disordered model, and the compound was modeled as formally neutral based on O-H and N-H distances. Room temperature analyses showed the proton transfer behavior to be independent of crystal temperature, and nuclear magnetic resonance studies show proton transfer behavior in solution. The formation of a zwitterionic hydrogen-bonded dimer is implicated in providing some stability during crystal growth of the easily crystallized 'three atom' chain compounds.

Entities:  

Year:  2010        PMID: 25425961      PMCID: PMC4241297          DOI: 10.1039/B923698H

Source DB:  PubMed          Journal:  CrystEngComm        ISSN: 1466-8033            Impact factor:   3.545


  9 in total

1.  Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.

Authors:  Yeon Sun Lee; Joel Nyberg; Sharif Moye; Richard S Agnes; Peg Davis; Shou-wu Ma; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2007-02-08       Impact factor: 2.823

2.  Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligands.

Authors:  Tingyou Li; Kimitaka Shiotani; Anna Miyazaki; Yuko Tsuda; Akihiro Ambo; Yusuke Sasaki; Yunden Jinsmaa; Ewa Marczak; Sharon D Bryant; Lawrence H Lazarus; Yoshio Okada
Journal:  J Med Chem       Date:  2007-05-12       Impact factor: 7.446

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 4.  Opioid formulations in development designed to curtail abuse: who is the target?

Authors:  Lynn R Webster; Brad Bath; Robert A Medve
Journal:  Expert Opin Investig Drugs       Date:  2009-03       Impact factor: 6.206

Review 5.  Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure.

Authors:  Michael H Ossipov; Josephine Lai; Tamara King; Todd W Vanderah; Frank Porreca
Journal:  Biopolymers       Date:  2005       Impact factor: 2.505

6.  Synthesis and evaluation of 3-aminopropionyl substituted fentanyl analogues for opioid activity.

Authors:  Ravil R Petrov; Ruben S Vardanyan; Yeon S Lee; Shou-wu Ma; Peg Davis; Lucinda J Begay; Josephine Y Lai; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2006-07-07       Impact factor: 2.823

7.  Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.

Authors:  Yeon Sun Lee; Ravil Petrov; Chad K Park; Shou-wu Ma; Peg Davis; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  J Med Chem       Date:  2007-10-10       Impact factor: 7.446

Review 8.  Antinociceptive and nociceptive actions of opioids.

Authors:  Michael H Ossipov; Josephine Lai; Tamara King; Todd W Vanderah; T Philip Malan; Victor J Hruby; Frank Porreca
Journal:  J Neurobiol       Date:  2004-10

9.  Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.

Authors:  Ruben Vardanyan; Gokhale Vijay; Gary S Nichol; Lu Liu; Isuru Kumarasinghe; Peg Davis; Todd Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2009-06-02       Impact factor: 3.641

  9 in total
  4 in total

1.  Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands.

Authors:  Ruben Vardanyan; Vlad K Kumirov; Gary S Nichol; Peg Davis; Erika Liktor-Busa; David Rankin; Eva Varga; Todd Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2011-08-24       Impact factor: 3.641

2.  Synthesis and Investigation of Mixed μ-Opioid and δ-Opioid Agonists as Possible Bivalent Ligands for Treatment of Pain.

Authors:  Ruben S Vardanyan; James P Cain; Saghar Mowlazadeh Haghighi; Vlad K Kumirov; Mary I McIntosh; Alexander J Sandweiss; Frank Porreca; Victor J Hruby
Journal:  J Heterocycl Chem       Date:  2016-06-01       Impact factor: 2.193

3.  Hyperpolarization of Pyridyl Fentalogues by Signal Amplification By Reversible Exchange (SABRE).

Authors:  Thomas B R Robertson; Lysbeth H Antonides; Nicolas Gilbert; Sophie L Benjamin; Stuart K Langley; Lindsey J Munro; Oliver B Sutcliffe; Ryan E Mewis
Journal:  ChemistryOpen       Date:  2019-11-08       Impact factor: 2.911

4.  Accurate prediction of terahertz spectra of molecular crystals of fentanyl and its analogs.

Authors:  Chun-Hung Wang; Anthony C Terracciano; Artёm E Masunov; Mengyu Xu; Subith S Vasu
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.